A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Journal
-
- Annals of Oncology
-
Annals of Oncology 28 (11), 2820-2826, 2017-11
Elsevier BV
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1361418519438715776
-
- ISSN
- 09237534
-
- Data Source
-
- Crossref